Skip to content

Haematology in Practice (HiP) was a GSK-led, non-promotional medical education programme delivered in Birmingham on 2-3 February 2026. The programme provided high-quality medical education and facilitated multidisciplinary discussion among UK clinicians with a special interest in myelofibrosis (Day 1) and multiple myeloma (Day 2).

The meeting was designed in collaboration between GSK and two groups of clinical experts specialising in either myelofibrosis or multiple myeloma to bring the most relevant and up to date content to the clinical community in the UK.

It brought together over 100 clinicians across the UK to discuss subjects around disease management and holistic patient care in a multidisciplinary fashion. Due to positive feedback from delegates attending the meeting, GSK would like to share the content from this event with a wide UK clinical community via recorded video sessions from both days of the event that can be found on this page.

Haematology in Practice: highlights from Myelofibrosis and Multiple Myeloma days

Myelofibrosis sessions

Best Practice Sharing on Clinical Monitoring in Myelofibrosis

Dr. Nauman Butt, Consultant Haematologist, The Clatterbridge Cancer Centre, Liverpool

A Nurse's Perspective on Holistic Management of Symptoms and Quality of Life

Claire Woodley, Advanced Nurse Practitioner, Guy's and St Thomas' NHS Foundation Trust, London

Allo-HCT for Myelofibrosis - Who and When?

Prof. Donal McLornan, Consultant Haematologist, University College London Hospitals

Cutaneous Squamous Cell Carcinoma in JAK inhibitor-treated MPN

Dr. Amaya Viros, Advanced Cancer Research UK Clinician Scientist, CRUK Manchester Institute

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.

©2024 GSK group of companies. All rights reserved.

October 2026 | NX-GB-ON-WCNT-260002